Clinical Trial Update: Acamprosate to Reduce Symptoms of Alcohol Withdrawal [Phase 2]

View source ↗

Summary

Phase 2 trial investigated whether acamprosate reduces symptoms of alcohol withdrawal and has completed enrollment, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Alcohol Use Disorder

Drugs mentioned

• acamprosate (acamprosate)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Alcohol-Related Disorders, Alcohol Dependence | Phase 2 | Status: COMPLETED | Results posted: 2012-01-05